CAPRICOR THERAPEUTICS, INC. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- CAPRICOR THERAPEUTICS, INC. payments for repurchase of common stock for the quarter ending 2019-12-31 was $0.00.
- CAPRICOR THERAPEUTICS, INC. payments for repurchase of common stock for the quarter ending 2019-09-30 was $0.00.
- CAPRICOR THERAPEUTICS, INC. payments for repurchase of common stock for the quarter ending 2018-12-31 was $0.00.
- CAPRICOR THERAPEUTICS, INC. payments for repurchase of common stock for the quarter ending 2018-09-30 was $0.00.
- CAPRICOR THERAPEUTICS, INC. payments for repurchase of common stock for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- CAPRICOR THERAPEUTICS, INC. payments for repurchase of common stock for fiscal 2019 was $193.00.
- CAPRICOR THERAPEUTICS, INC. payments for repurchase of common stock for fiscal 2018 was $0.00.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-15 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $193.00 10-K · filed 2021-03-15 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $0.00 10-K · filed 2020-03-27 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |